Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics: Information on the total number of voting rights and shares (May 2020)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (May 2020)

Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study

  • Read more about Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study

Bone Therapeutics to host Annual Ordinary General Meeting on 10 June 2020

  • Read more about Bone Therapeutics to host Annual Ordinary General Meeting on 10 June 2020

Bone Therapeutics raises additional EUR 4.0 million, with total of EUR 15 million committed, providing runway into Q2 2021

  • Read more about Bone Therapeutics raises additional EUR 4.0 million, with total of EUR 15 million committed, providing runway into Q2 2021

Bone Therapeutics Provides First Quarter 2020 Business Update

  • Read more about Bone Therapeutics Provides First Quarter 2020 Business Update

Bone Therapeutics secures EUR 11.0 million financing

  • Read more about Bone Therapeutics secures EUR 11.0 million financing

Bone Therapeutics: Information on the total number of voting rights and shares (March 2020)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (March 2020)

Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer

  • Read more about Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer

Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates

  • Read more about Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates

Bone Therapeutics announces 2019 full year results

  • Read more about Bone Therapeutics announces 2019 full year results

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions